Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$46.85 - $61.05 $2,670 - $3,479
-57 Closed
0 $0
Q1 2020

Apr 20, 2020

SELL
$41.6 - $63.4 $38,771 - $59,088
-932 Reduced 94.24%
57 $3,000
Q4 2019

Jan 31, 2020

BUY
$53.85 - $65.27 $3,069 - $3,720
57 Added 6.12%
989 $60,000
Q2 2019

Aug 07, 2019

BUY
$62.09 - $86.14 $57,867 - $80,282
932 New
932 $60,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.1B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Ls Investment Advisors, LLC Portfolio

Follow Ls Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.